KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 89 filers reported holding KEROS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $354,666 | +65.5% | 8,306 | +86.1% | 0.00% | +100.0% |
| Q4 2022 | $214,265 | +1847.9% | 4,462 | +1412.5% | 0.00% | – |
| Q3 2022 | $11,000 | -98.4% | 295 | -98.8% | 0.00% | -100.0% |
| Q2 2022 | $673,000 | +5076.9% | 24,346 | +11276.6% | 0.00% | – |
| Q4 2021 | $13,000 | -93.4% | 214 | -95.7% | 0.00% | -100.0% |
| Q3 2021 | $197,000 | +3183.3% | 4,972 | +4872.0% | 0.00% | – |
| Q1 2021 | $6,000 | -57.1% | 100 | -50.0% | 0.00% | – |
| Q4 2020 | $14,000 | -60.0% | 200 | -77.9% | 0.00% | -100.0% |
| Q3 2020 | $35,000 | +2.9% | 907 | +1.0% | 0.00% | 0.0% |
| Q2 2020 | $34,000 | – | 898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |